Idacorp (IDA) traded down -0.33 % during a 24 hours period ending at 07:45 PM Central Europe on Tuesday 27th. One Idacorp stock can currently be bought for about USD 139.82 on popular exchanges. Current supply of Idacorp stocks is 57.8 mn. Idacorp has a current market capitalization of USD 8.2 bn and approximately USD 55 mn worth of Idacorp was traded on exchanges in the last 24 hours. Since last month end, Idacorp has traded 8.85 % up. Simple moving average of last 200 days is at USD 140.58. The highest price of past 52 weeks was recorded at USD 154.91 on 07/06/2026. 52 weeks low was at USD 124.12 on 12/09/2025.
Here is how related stocks have performed in the past 24 hours:
Onto Innovation (ONTO) traded up 2.44 % and now trades at USD 214.35. Current market capitalisation for Onto Innovation is USD 9.7 bn. Current price/earnings ratio for Onto Innovation is 74.25.
Old National (ONB) traded down -1.15 % and now trades at USD 25.03. Old National has a market capitalisation of USD 9.6 bn. Current price/earnings ratio for Old National is 10.34.
Zions Na (ZION) traded flat 0 % and now trades at USD 65.88. Zions Na has a market capitalisation of USD 9.7 bn. Zions Na has a current price to earnings ratio of 8.15. California Bank & Trust, a division of Zions Bancorporation, announced the appointment of Michael MacDonald as president. MacDonald will oversee the bank’s commercial, corporate and specialty industry divisions while continuing to lead Zions Capital Markets and serve on the parent company’s executive management committee. The move is intended to strengthen the bank’s focus on relationship‑driven regional banking combined with sophisticated institutional‑scale capital solutions. CEO Eric Ellingsen noted that MacDonald’s experience in building project finance and capital markets capabilities will support the bank’s strategic execution and market expansion across California. The appointment reflects Zions Bancorporation’s ongoing effort to align its divisions around experienced leadership and a unified approach to client service.
Acuity (AYI) traded flat 0 % and now trades at USD 322.22. Current market capitalisation for Acuity is USD 9.6 bn. Acuity has a current price to earnings ratio of 18.68. Acuity Inc. reported a series of insider‑transaction filings on 26 October 2026, showing several senior officers and directors acquiring or adjusting their holdings of the company’s common stock through Form 4 disclosures. The filings, dated 22 October, detail purchases of shares by the president and CEO, the senior vice presidents of finance, legal, and human resources, and the senior vice president of general counsel. Each transaction involved restricted‑stock‑unit awards under the company’s 2012 incentive plan, with vesting scheduled to begin in 2027. The filings also included a note that a portion of the holdings is held in a 401(k) plan, reflecting the company’s employee‑ownership program. Separately, Acuity announced a definitive agreement to acquire Parameter Technologies for a purchase price of approximately $675 million, with the transaction expected to close in late‑2026. The acquisition would place Parameter within Acuity’s Intelligent Spaces segment, expanding the company’s sensing, detection and monitoring capabilities in data‑center and critical‑infrastructure markets.
Bio-rad Laboratories (BIO-B) traded down -0.25 % and now trades at USD 364.15. Current market capitalisation for Bio-rad Laboratories is USD 9.7 bn. BIO‑RAD LABORATORIES has announced a new partnership that will enable the company to leverage advanced analytical capabilities for its drug development programmes. The collaboration involves integration of the partner’s high‑performance data‑processing platform, which is designed to support the identification of novel therapeutic targets and the optimization of clinical trial designs. BIO‑RAD has indicated that the alliance will accelerate the evaluation of its oncology assets, particularly those aimed at improving outcomes for patients with solid tumours. The company has expressed confidence that the enhanced data analytics will improve the precision of biomarker discovery and support regulatory submissions, thereby potentially shortening the time to market for its pipeline products.
About Idacorp
IDACORP, Inc. is a holding company that generates, purchases, transmits, distributes, and sells electricity in southern Idaho, eastern Oregon, northern Nevada, and Wyoming. Additionally, the company manages affordable housing projects and other real estate investments. You can find more information about their operations on their website at www.idacorpinc.com , and they are listed on the New York Stock Exchange.